Bausch Health group Ortho Dermatologics has resubmitted an application to market its plaque psoriasis lotion Duobrii in the US - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/ortho_resubmits_duobrii_in_the_us_1249157Janssen has submitted a marketing application to the European Medicines Agency (EMA) seeking approval of investigational nasal spray esketamine for the treatment of major depressive disorder. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/janssen_files_nasal_spray_for_depression_1255351Baxter has snapped up private German biotech SuppreMol and its operations in Munich for 200 million euros. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/baxter_buys_germanys_suppremol_971136Irish pharma Allergan is buying privately-held, clinical-stage US biotech Bonti for access to its novel, fast-acting neurotoxin programmes for aesthetic and therapeutic applications. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/allergan_snaps_up_bonti_1252557Novartis’ generics arm Sandoz has launched the second Healthcare Access Challenge (HACk), which is looking to support digital solutions to local healthcare access challenges. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/sandoz_launches_second_digital_health_competition_1254475Manchester, UK-based Concept Life Sciences, an integrated drug discovery, development and analytical services company, has acquired Scottish contract research organisation Aquila BioMedical. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/concept_buys_scottish_cro_aquila_1209900The inaugural PharmaTimes Sales Awards - established to recognise and celebrate the very best sales professionals in the industry today - will close for entries on September 7. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/pharmatimes_sales_awards_-_entry_deadline_approaching_1251413Astellas has acquired Cambridge, UK-based Quethera, a gene therapy group focused on the development of novel treatments for ocular disorders, such as glaucoma. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/astellas_buys_uk_group_quethera_1248690AstraZeneca has sold off certain rights to its antipsychotics Seroquel and Seroquel XR in certain territories - including the UK – to Luye Pharma. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/astrazeneca_sheds_seroquel_rights_1234663Merck is investing $125 million in Moderna under a new deal that expands the firms’ 2016 partnership to develop messenger RNA cancer vaccines. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/merck_invests_in_moderna_1234371
